Breast cancer is the second most common malignancy among women in Nepal. It is more common in young premenopausal women. Breast cancer continues to increase in incidence due to lifestyle changes in Nepalese women despite constant remarkable development in the management of this disease over the past three decades. Breast cancer was diagnosed solely clinically and surgery was the only treatment option until fi fty years ago. Multidisciplinary approach has been adopted for diagnosis and treatment of breast cancer in Nepal. Imaging is required for the diagnosis, appropriate treatment decision and proper follow up. Treatment modality depends upon the extent of the disease and tumor biology. However, there is a strong need for standard guidelines for the proper management of breast cancer in Nepal so that surgeries, chemotherapy, hormone therapy and radiotherapy are standardized in the country. Palliative care has been initiated to provide to some patients with metastatic breast cancer recently.
INTRODUCTION
Breast cancer is a major health problem to affect women worldwide. In Nepal also, as breast cancer continues to increase, all concerned people must act promptly to control this disease. Although there are a few comprehensive cancer centers in Nepal, breast cancer is managed at other centers with limited resources frequently. There is no uniformity in the guidelines of managing all breast cancer. The management of the breast carcinoma patients has undergone revolutionary changes over the past three decades worldwide. Some positive changes can be appreciable in Nepal too. The objective of this article is to analyze all the data for managing breast cancer in Nepal. A relevant search was made using PubMed, entering Breast cancer in Nepal as search sentence and information distilled and presented. In this article, we discuss about breast cancer incidence, detection and management, focusing on areas of clinical practice that has evolved in Nepal or where emerging evidence supports future directions in practice.
Incidence:
There is a marked geographical variation in the incidence of breast carcinoma worldwide. In the West (developed countries), the incidence of breast cancer is more than 1000 per million whereas in developing countries it is low (less than 200 per million women). However, cancer mortality is higher in developing countries than in the developed countries. 1 There is a lack of population-based cancer registry in Nepal. However, it is encouraging to note that some promising efforts have been initiated at least in terms of hospital based registry. 2, 3 Breast cancer accounts for 6% of all cancers in Nepal. 4 A recent multi-institution hospital-based cancer incidence data revealed breast cancer as the second most common cancer among women in Nepal. 2 The commonest age group of women with breast cancer in Nepal is 40-50 years. One of the most remarkable differences is higher incidence of younger breast cancer women (<50 yr) in our part of the world.
Risk Factors:
The effect of endogenous hormones is a major contributing factor for the etiology of breast cancer. Among hormonal factors, reproductive history such as nulliparity, early age at menarche, late age at menopause and late age at fi rst full-term pregnancy is associated with an increased risk. 5 However, Nepalese breast cancer is commonly seen in young age with late menarche, early fi rst full-term pregnancy, a long duration of lactation. 6, 7 A family history positive for breast cancer produces an increased risk. 5 In young patients, genetically inherited susceptibility to breast cancer is well described. Family history of breast carcinoma in fi rst degree relatives is rare in Nepal. 6, 7 None of the known reproductive factors can adequately explain the early occurrence of premenopausal Nepalese breast cancer. Due to modernization and development in urban areas of Nepal, there has been a large infl ux of people into these areas. Life style changes like dietary habits, lack of physical exercise, less breast feeding by mothers, are seen more frequently in urban women. These factors might contribute to an increased risk of breast cancer.
Early Detection and Screening:
Patients with early breast cancers are usually asymptomatic. Early detection and screening programs are established in order to reduce the breast cancer mortality. Breast Self-Examination (BSE) and clinical breast examination are the key steps for the early detection of breast cancer in resource limited countries like Nepal. BSE is an inexpensive tool for creating breast cancer awareness although it does not provide survival benefi t. If a woman practices BSE regularly, she is not only conscious about breast cancer but also about her health in general. The evidence shows that screening mammography and proper examination of breasts can be useful in reducing breast cancer mortality. 8 However, a population based study from eastern region of Nepal concluded that BSE could be used as an important tool for primary prevention of breast cancer in Nepal. 9 Clinical breast examination by trained female nurses has been initiated as a pilot screening program recently. At present, breast cancer screening by mammogram is not feasible due to unavailability of this facility at many centers though few early cancers can be detected by mammograms. 10 High-resolution ultrasound can detect very small lesions, and more reliably differentiates malignant from benign solid masses. 11, 12 However, ultrasound remains unproven as a screening tool, and its potential role in screening is likely to be limited in cases where mammography can not detect lesions in young women with dense breasts.
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Presentation:
The average age of breast cancer is 46.5±12.8 years ranging from 25 to 80 years. 7 The diagnosis of asymptomatic breast cancer is rare in Nepal. Painless breast lump is the commonest presentation (80-90%) which is ignored by many women in developing countries including Nepal. The duration of symptoms varies from 8 to 13 months which has decreased to 4 to 5 months recently. 6, 7 More than half of them (60%) are premenopausal young women (<50 year). The ratio of pre-to post-menopausal breast cancer is 6 to 4 in Nepal whereas it is 4 to 6 in the West.
14 Nepalese breast cancer cases, particularly premenopausal breast cancer patients, are seen at a young age with late menarche, early fi rst full-term pregnancy, long duration of lactation and a large number of children. 7 The mean tumor size is 6.1±2.5 cm ranging from 1.3 to 20 cm which has come down to 3.9 cm recently. 7 Staging of breast cancer is a part of pretreatment evaluation to assess the extent of the disease and treatment. Although the trend is improving to present early, more than half of our breast cancer patients present in late stage (III or IV). The recent data at our institute reveal carcinoma in situ (1%), stage I (7%), stage II (IIA 19%, IIB 23%), stage III (IIIA 18%, IIIB 22%), and stage IV (10%).
Imaging:
Remarkable changes have been seen in breast imaging and diagnostic modalities of breast cancer. Over the year imaging has a key role for accurate diagnosis, appropriate treatment selection and follow-up plan. Mammography is routinely done for all women over the age of 40 years attending symptomatic breast clinics. High-resolution ultrasound is an effective diagnostic tool for focal breast symptoms. Mammogram and breast ultrasound services are available at a few centers in Nepal. Based on one study only 68% of our breast cancer patients had undergone mammography before surgery. 10 This may be due to unavailability of mammogram in the center where breast cancer is managed frequently. Breast carcinoma was identifi ed on mammography in 87% of cases. In the rest of the patients (reported as either normal or benign lesions), the diagnosis was missed in mainly younger and premenopausal groups of women. The diagnostic accuracy for carcinomas of the breast appears to improve when mammography is combined with ultrasonogram even in cases that reveal no evidence of microcalcifi cation or other abnormalities. 15 Magnetic resonance imaging (MRI) of the breast is not routinely used in the diagnosis. However, it is an important tool for evaluating the extent of the disease (multifocality) where this cannot be reliably excluded on conventional imaging. 16 Interest in breast MRI in recent years has largely focused on its role in screening women with inherited mutations of the breast cancer genes (BRCA1 or BRCA2).
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Pathology:
Histocytological diagnosis has a pivotal role for the defi nitive treatment of breast cancer. The commonest diagnostic modality of breast lump is to perform fi ne needle aspiration cytology (FNAC) before further evaluation or operative treatment. 18 FNAC is a popular technique because it is a simple, safe and quick procedure with high sensitivity and specifi city. 19 The accuracy rate of FNAC in diagnosing breast cancer is up to 96%. 20, 21 Other than morphological prognostic factors, molecular predictive factors are essential to predict response to systemic treatments such as hormone receptors, HER-2 and so on. Fortunately this facility is available. Less than 40% of our breast cancers are hormone receptors (Estrogen and/or Progesterone) positive. 10 In the West or Japan, the hormone receptor positive rate is more than 60%. 22 FNAC is commonly used in addition to clinical examination and mammography for the diagnosis of breast lesions. 23 Triple test score (physical examination, mammography and fi ne needle aspiration cytology, each component is designated as benign, suspicious and malignant and rated as 1, 2, and 3, respectively) can be an accurate diagnostic modality to initiate defi nitive treatment of breast carcinoma specially in our context where frozen section is not routinely available. 24 Percutaneous core needle biopsy (CNB) has widely replaced cytology obtained by fi ne-needle aspiration, and is the established method of sampling imagedetected lesions. 25 CNB provides more information than FNAC and assists in planning therapy before surgery in women with cancer, as it reliably distinguishes between invasive and in-situ disease, and allows determination of hormone and growth factor receptors.
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Surgery:
The local treatment of breast cancer can be performed in order to achieve a long-term local disease control with minimum local morbidity. Breast conserving surgery (BCS) produces an acceptable cosmetic appearance. 27 So that less anxiety and depression and improved body image and sexuality when compared with mastectomy. 28 Moreover, there is no difference in disease outcome between BCS in combined with radiotherapy and mastectomy. 29, 30 The history of breast cancer surgery is as old as the history of surgery in Nepal. Until four decades back radical mastectomy was the main surgical option for breast cancer. The majority of women presenting to the hospital have large breast cancers, which are not suitable for breast conserving surgery. There is slowly changing trend of breast conserving surgery (BCS) in Nepal. The recent trends of BCS at BPKMCH, Bharatpur and our institute (TUTH) are 6% and 15%, respectively. The majority of them undergo total mastectomy with axillary lymph nodes dissection of level I and II. 6 Moreover, BCS is not offered in the centers where proper preoperative evaluation facility and postoperative radiotherapy are not available. Axillary lymph node status is the most signifi cant individual prognostic factor in breast cancer patients. 31 Both adjuvant systemic and locoregional treatments depend upon this factor. Standard management of the axilla has been axillary node dissection. However this procedure is associated with signifi cant morbidity and provides no benefi t for most breast cancer patients without axillary lymph node involvement. Surgical staging by axillary lymph node dissection is the usual practice in Nepal. Frozen section is not widely available. Ultrasound of the axilla can identify enlarged or abnormal nodes in up to half of the patients with breast cancer and FNAC or core biopsy of the nodes identifi es up to 40% of patients with involved axillary nodes. 32 Sentinel lymph node biopsy accurately assesses lymph node status and is associated with less morbidity than axillary dissection. 33 Sentinel node mapping and biopsy are in the initial phase of use in Nepal. 34, 35 Breast reconstruction after mastectomy can produce good cosmetic results, especially where autologous tissue is used. Myocutaneous fl aps using latissimus dorsi or transverse rectus abdominus muscles are increasingly used. 36 Although breast reconstruction plays a remarkable role in woman's physical, emotional and psychological recovery from breast cancer, immediate or delayed breast reconstruction is rarely performed in Nepal. However, chest wall reconstruction has been performed for breast cancer. 37, 38 Radiation Therapy:
Factors affecting the local recurrence include patient factors (e.g. young age), disease factors (e.g. extensive intraductal component, lymphovascular invasion and grade) and treatment factors (e.g. resection margins, intensity of radiotherapy and adjuvant systemic therapy). 39 Radiotherapy has a crucial role in the control of postoperative breast cancer risk. There is a defi nite effi cacy of breast conserving surgery and radiotherapy in terms of survival. Radiotherapy reduces the rate of local recurrence after breast conserving surgery and improves overall survival. 40 Post-mastectomy radiotherapy is associated with a 66% reduction in risk of local recurrence. 29 Moreover, there is a signifi cant overall survival benefi t associated with adjuvant therapy in those treated by mastectomy alone or mastectomy and axillary clearance. The addition of axillary irradiation post axillary lymph node dissection may be benefi cial when it is likelihood of residual disease in the axilla. There is regional variation in the use of radiation therapy in Nepal. 6 
Systemic Therapy:
Breast cancer was the fi rst malignancy for which effective systemic therapy was developed. 41 Endocrine therapies are designed to counteract the proliferative effect of estrogen in estrogen receptor-positive breast cancer. Tamoxifen is currently the most widely used hormonal therapy. 42 Tamoxifen-users require routine testing for endometrial evaluation. 43 Aromatase inhibitors reduce estrogen production in postmenopausal women by inhibiting or inactivating an enzyme, aromatase. 44 However, these inhibitors are ineffective in premenopausal women because they produce an increase in gonadotrophin secretion, which results in reduced feedback of estrogen. The selective estrogen receptor modulators such as aromatase inhibitors are also available in Nepal. However, these are expensive compared to Tamoxifen, the later is used even in postmenopausal women who cannot afford aromatase inhibitors.
There are many cytotoxic agents used in breast cancer either in post or pre operative settings. Anthracyclinebased chemotherapy regimen is commonly used in Nepal. 45 Selection of adjuvant treatment is determined by prognostic factors. Preoperative chemotherapy increases the chance of BCS rather than mastectomy. 46 Trastuzumab is a novel human monoclonal antibody that specifi cally targets HER-2 (predictive factor) and achieves good response in HER-2 positive breast cancer. 47 Although trastuzumab, a very expensive molecule restricting its use to a selected group of patients, is available in Nepal.
Palliative Care:
Palliative care has a crucial role to improve the quality of life of women with metastatic breast disease. 48 Pain is the most common and the most feared symptom to be controlled in cancer patients. There are special pain situations common in metastatic breast cancer. Pain secondary to bone metastasis is an alarming situation and needs specifi c management. Radiotherapy is the treatment of choice for the palliation of metastatic bone disease. 49 Single fraction has been shown to be a very effective way in the achievement of pain control. Biphosphonates are recommended for routine breast cancer treatment in order to reduce the skeletal morbidity and also to control bone pain. 50 Radiotherapy can be combined with early systemic therapy with biphosphonates to reduce morbidity of bone metastases. Palliative care services are in initial phases of development in Nepal. 51 
Cancer Education:
Most Nepalese women are not aware of the risk factors associated with breast cancer. Education status of the women in Nepal has a crucial value in the management of breast cancer. An educated woman understands her disease better and participates actively in the treatment process. Breast cancer awareness programs should be extended to the rural areas of Nepal where mass communication means are not adequate. Moreover, the educational difference between the patient and the specialized physician may create an atmosphere where there is little respect conveyed to the patient. Regular cancer education and appropriate trainings are important for treating physicians and nurses in order to improve the quality of service. 52 In summary, cancer care is on the rise and breast cancer can be 'cured' even in Nepal. Cancer awareness particularly to women is the key factor for successful cancer control. Screening and early detection programs are extended throughout the country. A standard breast cancer treatment protocol should be followed by all the centers in order to measure the treatment outcomes. Although there are a few comprehensive cancer centers in Nepal, most of the centers are treating these cancer patients with limited resources.
